Ducore, J. M., Fischer, K., Kulkarni, R., Nolan, B., Bennett, C. M., Perry, D. J., . . . Lethagen, S. (2016). Long Term Safety and Efficacy of Recombinant Factor IX Fc Fusion Protein (rFIXFc) Prophylaxis in Children with Hemophilia B: Interim Results of the B-Yond Extension Study. Blood, 128(22), 4976. https://doi.org/10.1182/blood.V128.22.4976.4976
Chicago Style (17th ed.) CitationDucore, Jonathan M., et al. "Long Term Safety and Efficacy of Recombinant Factor IX Fc Fusion Protein (rFIXFc) Prophylaxis in Children with Hemophilia B: Interim Results of the B-Yond Extension Study." Blood 128, no. 22 (2016): 4976. https://doi.org/10.1182/blood.V128.22.4976.4976.
MLA (9th ed.) CitationDucore, Jonathan M., et al. "Long Term Safety and Efficacy of Recombinant Factor IX Fc Fusion Protein (rFIXFc) Prophylaxis in Children with Hemophilia B: Interim Results of the B-Yond Extension Study." Blood, vol. 128, no. 22, 2016, p. 4976, https://doi.org/10.1182/blood.V128.22.4976.4976.